financetom
Business
financetom
/
Business
/
Dell Poised for AI-Led More Durable Growth Despite Near-Term Headwinds, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dell Poised for AI-Led More Durable Growth Despite Near-Term Headwinds, UBS Says
May 31, 2024 9:07 AM

11:56 AM EDT, 05/31/2024 (MT Newswires) -- Dell Technologies ( DELL ) is expected to see more durable growth than previously expected, led by artificial intelligence server momentum and AI personal computers in the next two years despite near-term challenges, UBS Securities said in a note e-mailed Friday.

The computer maker late Thursday posted fiscal first-quarter adjusted earnings of $1.27 a share, down from $1.31 a year earlier, while revenue rose 6% to $22.24 billion. The results topped UBS' expectations for $1.17 and $21.6 billion, respectively. The company's gross margin saw pressure from growth in AI servers and a "more competitive" pricing backdrop, UBS analysts David Vogt, Andrew Spinola and Brian Luke said.

"While we acknowledge heightened AI expectations heading into the print results in a near-term reset in the share price, we continue to expect a strong ramp of AI servers from roughly (35,000) units in (fiscal 2025) to (about 50,000) units in (2026)," the analysts said. "Therefore, we believe the risk/reward is still favorable, albeit with a share price reset."

Dell's shares were plunging 22% in Friday trading. Given inflationary input costs, the competitive backdrop and a higher mix of AI-optimized servers, gross margins are expected to decline about 150 basis points this year, Chief Financial Officer Yvonne McGill said on an earnings conference call late Thursday, according to a Capital IQ transcript.

Demand signals and the company's backlog of $3.8 billion indicate AI server revenue is expected to grow "a couple hundred million" in the ongoing quarter to about $1.9 billion, according to the note. Given the timing around order placements, UBS expects "just under" $4 billion in the second half of the year. AI server demand by large hyperscalers and tier-2 cloud providers is "more robust" this year and likely next year than UBS expected 90 days ago, but likely below the market's elevated outlook, according to the note.

"While we continue to be constructive on AI server demand, (particularly) at enterprises over the next several years, we note we have been more conservative than the (market) with regards to the financial impact given the (graphics processing unit) in a server is the key driver of reported (revenue) growth and is largely a 'pass-through'," the analysts said. The brokerage expects AI PCs to be "a more material" financial contributor in the next two years.

For the full-year, the company expects adjusted EPS of $7.65, plus or minus $0.25 and revenue of $93.5 billion to $97.5 billion, McGill said on the call. Wall Street is looking for $7.73 and $95.76 billion, respectively. The company pegs second-quarter adjusted EPS at $1.65, plus or minus $0.10 on revenue of $23.5 billion to $24.5 billion, versus the Street's views for $1.70 and $23.72 billion, respectively.

"We expect the AI momentum we've seen over the past (three) quarters to continue, driving incremental revenue for the year," McGill told analysts. "In our core businesses, while the macro environment is still dynamic, our indicators point toward a stabilization with improvement as we progress through the year."

UBS increased its price target on the Dell stock to $164 from $141, with a buy rating. "While share price upside potential is more modest over the next 12 months relative to the past 12 months, we still view Dell as a secular winner in AI servers over the next several years," the analysts said.

Price: 133.88, Change: -36.04, Percent Change: -21.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved